Next Article in Journal
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Previous Article in Journal
Investigation of the Protection of the C4 Hydroxyl Group in Macrobicyclic Kdo Donors
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042

1
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Applied BioChemistry Lab, Department of Biological Sciences, Aliah University, Kolkata 700160, India
4
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 22254, Saudi Arabia
5
Department of Chemistry, School of Life and Basic Sciences, SIILAS Campus, Jaipur National University, Jaipur 302017, India
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(1), 104; https://doi.org/10.3390/molecules28010104
Submission received: 27 October 2022 / Accepted: 28 November 2022 / Published: 23 December 2022
Due to miscommunication, in the original publication there is a discrepancy in the project number and funding institution, located in Funding Information and Acknowledgement [1]. The correct funding information should be as follows:
Original:
Funding: Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [Grant number IFPRC-146-141-2020].
This should be replaced with:
Funding: This research work was funded by Institutional Fund Projects under grant No. (IFPDP-39-22).
The authors state that the scientific conclusions are unaffected. All co-authors agree with the content of this correction and wish to apologize for any inconvenience caused for the readers resulting from this error.

Reference

  1. Tabrez, S.; Zughaibi, T.A.; Hoque, M.; Suhail, M.; Khan, M.I.; Khan, A.U. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tabrez, S.; Zughaibi, T.A.; Hoque, M.; Suhail, M.; Khan, M.I.; Khan, A.U. Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042. Molecules 2023, 28, 104. https://doi.org/10.3390/molecules28010104

AMA Style

Tabrez S, Zughaibi TA, Hoque M, Suhail M, Khan MI, Khan AU. Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042. Molecules. 2023; 28(1):104. https://doi.org/10.3390/molecules28010104

Chicago/Turabian Style

Tabrez, Shams, Torki A. Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan, and Azhar U. Khan. 2023. "Correction: Tabrez et al. Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 2022, 27, 5042" Molecules 28, no. 1: 104. https://doi.org/10.3390/molecules28010104

Article Metrics

Back to TopTop